Division of Critical Care Medicine, Department of Medicine, Cooper University Health Care, Cooper Medical School of Rowan University, Camden, NJ.
Division of Nephrology, Department of Medicine, Cooper University Health Care, Cooper Medical School of Rowan University, Camden, NJ.
Crit Care Med. 2019 May;47(5):715-721. doi: 10.1097/CCM.0000000000003701.
The incidence of acute kidney injury in critically ill patients is increasing steeply. Acute kidney injury in this setting is associated with high morbidity and mortality. There is no doubt that renal replacement therapy for the most severe forms of acute kidney injury can be life saving, but there are a number of uncertainties about the optimal application of renal replacement therapy for patients with acute kidney injury. The objective of this synthetic review is to present current evidence supporting best practices in renal replacement therapy for critically ill patients with acute kidney injury.
We reviewed literature regarding timing of initiation of renal replacement therapy, optimal vascular access for renal replacement therapy in acute kidney injury, modality selection and dose or intensity of renal replacement therapy, and anticoagulation during renal replacement therapy, using the following databases: MEDLINE and PubMed. We also reviewed bibliographic citations of retrieved articles.
We reviewed only English language articles.
Current evidence sheds light on many areas of controversy regarding renal replacement therapy in acute kidney injury, providing a foundation for best practices. Nonetheless, important questions remain to be answered by ongoing and future investigation.
危重症患者急性肾损伤的发病率急剧上升。在这种情况下,急性肾损伤与高发病率和死亡率相关。毫无疑问,对于最严重形式的急性肾损伤,肾脏替代疗法可以挽救生命,但对于急性肾损伤患者最佳应用肾脏替代疗法仍存在一些不确定因素。本综合综述的目的是提出目前支持危重症急性肾损伤患者肾脏替代疗法最佳实践的证据。
我们使用以下数据库,回顾了关于肾脏替代疗法开始时机、急性肾损伤中肾脏替代疗法的最佳血管通路、治疗方式选择以及肾脏替代疗法剂量或强度,以及肾脏替代疗法期间抗凝等方面的文献,并对检索到的文章的参考文献进行了回顾。
我们仅回顾了英语语言的文章。
目前的证据阐明了急性肾损伤中肾脏替代疗法许多有争议的领域,为最佳实践提供了基础。尽管如此,仍有一些重要问题需要通过正在进行和未来的研究来解答。